EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57

Abstract

KNOWLEDGE AND PRACTICE OF PRESCRIBERS REGARDING WHO ETHICAL CRITERIA FOR DRUG PROMOTIONAL ADVERTISEMENTS

Ravinder K. Sah ?, Rakhamaji D. Chandane, Anita H. Yuwnate, Manik S. Ghadlinge, Sumit kulhare

ABSTRACT

Background: Drug promotional advertisements (DPAs) provides bias and ambiguous information as pharmaceutical companies do not strictly follow the guidelines therefore promoting irrational prescribing by influencing prescriber’s prescribing behaviour. Hence this study was planned to asses’ knowledge and practice of prescribers regarding WHO ethical criteria for DPAs. Material and method: This cross-sectional questionnaire-based study containing 9 items regarding WHO criteria for rationality of the DPAs was conducted on 100 doctors posted in various outpatient departments of Lady Harding Medical College and associated hospitals. Results: It was found that 79% of respondents were not aware that false pharmaceutical advertisements are illegal under Drug and Magic remedies Act 1954 in India. Doctors preferred DPAs (40%) as a main source of drug information which influences their prescribing pattern. Originality and easiness of data & graphs of DPAs were never evaluated by 66 (85.7%) and 62 (80.5%) of prescribers respectively. Retrievability of the references was never evaluated by 86.5% of prescribers. Claims regarding efficacy was evaluated by 100% of prescribers. Bias in racial and ethical composition of people and social representation were not evaluated by 92.3% and 90.7% of prescribers respectively. Conclusion: Prescribers did not analyze DPAs as per WHO criteria for rationality because of lack of knowledge and practice. Hence there are strong need to improve knowledge and practice of prescribers regarding use of WHO criteria for rationality of the DPAs to promote rational prescribing.

Keywords: Drug Promotional Advertisements, WHO, Prescribers, Knowledge, Practice.


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 March 2024 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: MARCH ISSUE PUBLISHED

    MARCH 2024 issue has been successfully launched on MARCH 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia